Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival

Joanna R M Armstrong Schellenberg, Werner Maokola, Kizito Shirima, Fatuma Manzi, Mwifadhi Mrisho, Adiel Mushi, Pedro Alonso, Hassan Mshinda, Marcel Tanner, David M Schellenberg, Joanna R M Armstrong Schellenberg, Werner Maokola, Kizito Shirima, Fatuma Manzi, Mwifadhi Mrisho, Adiel Mushi, Pedro Alonso, Hassan Mshinda, Marcel Tanner, David M Schellenberg

Abstract

Background: Intermittent Preventive Treatment for malaria control in infants (IPTi) consists of the administration of a treatment dose of an anti-malarial drug, usually sulphadoxine-pyrimethamine, at scheduled intervals, regardless of the presence of Plasmodium falciparum infection. A pooled analysis of individually randomized trials reported that IPTi reduced clinical episodes by 30%. This study evaluated the effect of IPTi on child survival in the context of a five-district implementation project in southern Tanzania. [

Trial registration: clinicaltrials.gov NCT00152204].

Methods: After baseline household and health facility surveys in 2004, five districts comprising 24 divisions were randomly assigned either to receive IPTi (n = 12) or not (n = 12). Implementation started in March 2005, led by routine health services with support from the research team. In 2007, a large household survey was undertaken to assess the impact of IPTi on survival in infants aged two-11 months through birth history interviews with all women aged 13-49 years. The analysis is based on an "intention-to-treat" ecological design, with survival outcomes analysed according to the cluster in which the mothers lived.

Results: Survival in infants aged two-11 months was comparable in IPTi and comparison areas at baseline. In intervention areas in 2007, 48% of children aged 12-23 months had documented evidence of receiving three doses of IPTi, compared to 2% in comparison areas (P < 0.0001). Over the three years of the study there was a marked improvement in survival in both groups. Between 2001-4 and 2005-7, mortality rates in two-11 month olds fell from 34.1 to 23.6 per 1,000 person-years in intervention areas and from 32.3 to 20.7 in comparison areas. In 2007, divisions implementing IPTi had a 14% (95% CI -12%, 49%) higher mortality rate in two-11 month olds in comparison with non-implementing divisions (P = 0.31).

Conclusion: The lack of evidence of an effect of IPTi on survival could be a false negative result due to a lack of power or imbalance of unmeasured confounders. Alternatively, there could be no mortality impact of IPTi due to low coverage, late administration, drug resistance, decreased malaria transmission or improvements in vector control and case management. This study raises important questions for programme evaluation design.

Figures

Figure 1
Figure 1
Trial profile.
Figure 2
Figure 2
Mortality in infants aged two-11 months.
Figure 3
Figure 3
Mortality change in infants aged two-11 months by IPTi coverage, intervention divisions.
Figure 4
Figure 4
Model of impact for IPTi.

References

    1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533–1542.
    1. de Savigny D, Adam T. In: Systems thinking for health systems strengthening. Alliance for Health Policy and Systems Research, editor. World Health Organisation: Geneva; 2009.
    1. Manzi F, Hutton G, Schellenberg J, Tanner M, Alonso P, Mshinda H, Schellenberg D. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Services Research. 2008;8:165.
    1. Manzi F, Schellenberg J, Hamis Y, Mushi AK, Shirima K, Mwita A, Simba A, Rusibamayila N, Kitambi M, Tanner M, Alonso P, Mshinda H, Schellenberg D. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy. Trans Roy Soc Trop Med Hyg. 2009;103:79–86.
    1. Pool R, Mushi A, Schellenberg JA, Mrisho M, Alonso P, Montgomery C, Tanner M, Mshinda H, Schellenberg D. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malaria Journal. 2008;7:213.
    1. Mushi AK, Schellenberg J, Mrisho M, Manzi F, Mbuya C, Mponda H, Mshinda H, Tanner M, Alonso P, Pool R, Schellenberg D. Development of behaviour change communication strategy for a vaccination-linked malaria control tool in Southern Tanzania. Malaria Journal. 2008;7:191.
    1. Armstrong Schellenberg JR, Mrisho M, Manzi F, Shirima K, Mbuya C, Mushi AK, Ketende SC, Alonso PL, Mshinda H, Tanner M, Schellenberg D. Health and survival of young children in southern Tanzania. BMC Public Health. 2008;8:194.
    1. Armstrong Schellenberg JRM, Shirima K, Maokola W, Manzi F, Mrisho M, Mushi A, Mshinda H, Alonso P, Tanner M, Schellenberg D. Community effectiveness of Intermittent Preventive Treatment for infants (IPTi) in rural southern Tanzania. Am J Trop Med Hyg. 2010;82:772–81.
    1. Willey BA, Armstrong Schellenberg JR, Maokola W, Shirima K, Chemba M, Mshinda H, Alonso P, Tanner M, Schellenberg D. Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania. Malaria Journal. 2011;10:41.
    1. National Bureau of Statistics (NBS) [Tanzania] and ORC Macro. Tanzania Demographic and Health Survey. Dar es Salaam, Tanzania: National Bureau of Statistics and ORC Macro; 2005.
    1. National Bureau of Statistics (NBS) [Tanzania] 2002 Tanzanian Population and Housing Census Census Analytical Report. Dar es Salaam. 2006.
    1. Shirima K, Mukasa O, Schellenberg JA, Manzi F, John D, Mushi A, Mrisho M, Tanner M, Mshinda H, Schellenberg D. The use of personal digital assistants for data entry at the point of collection in a large household survey in southern Tanzania. Emerging Themes in Epidemiology. 2007;4:5.
    1. Hayes RJ, Moulton LH. Cluster randomised trials. Boca Ranton: Taylor & Francis; 2009.
    1. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M, Mshinda H, Alonso P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet. 2001;357:1471–1477.
    1. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004. p. CD000363.
    1. Bradley DJ. In: Disease and Mortality in Sub-Saharan Africa. Feachem RG, Jamison DT, editor. World Bank; 1991. Morbidity and mortality at Pare-Taveta, Kenya and Tanzania, 1954-1966: the effects of a period of malaria control; pp. 248–263.
    1. Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS ONE. 2010;5:9467.
    1. Mushi A. Reaching the poorest children in rural southern Tanzania: sociocultural perspectives for delivery and uptake of preventive child health interventions. London School of Hygiene and Tropical Medicine: London; 2009.
    1. Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants. J Infect Dis. 2008;197:1737–42.
    1. Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: A randomized, placebo controlled trial. J Inf Dis. 2006;194:276–285.
    1. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1521–32.
    1. El Arifeen S, Blum LS, Hoque DM, Chowdhury EK, Khan R, Black RE, Victora CG, Bryce J. Integrated Management of Childhood Illness (IMCI) in Bangladesh: early findings from a cluster-randomised study. Lancet. 2004;364:1595–602.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner